ORCA
Online Research @ Cardiff
Browse by All Cardiff Authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 5.
Mukherjee, Somnath, Hurt, Christopher  ORCID: https://orcid.org/0000-0003-1206-8355, Radhakrishna, Ganesh, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Hawkins, Maria A., Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Grabsch, Heike I., Falk, Stephen, Sharma, Ricky A., Ray, Ruby, Roy, Rajarshi, Cox, Catrin, Maynard, Nick, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Sebag-Montefiore, David J., Maughan, Timothy, Griffiths, Gareth O. and Crosby, Tom D.L.
2021.
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial.
European Journal of Cancer
153
, pp. 153-161.
10.1016/j.ejca.2021.05.020
|
|
|
Goulart, Michelle R., Watt, Jennifer, Siddiqui, Imran, Lawlor, Rita T., Imrali, Ahmet, Hughes, Christine, Saad, Amina, ChinAleong, Joanne, Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355, Cox, Catrin, Salvia, Roberto, Mantovani, Alberto, Crnogorac-Jurcevic, Tatjana, Mukherjee, Somnath, Scarpa, Aldo, Allavena, Paola and Kocher, Hemant M.
2021.
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma.
npj Precision Oncology
5
(1)
, 61.
10.1038/s41698-021-00192-1
|
|
|
|
Moss, Laura, Cox, Catrin, Wadsley, Jonathan, Newbold, Kate, Strachan, Mark W.J., Druce, Maralyn, Tolley, Neil, Graham, Kathryn, Jefferies, Sarah, Fresco, Lydia, Sivabalasingham, Suganya, Balfour, Alistair and Hurt, Chris ORCID: https://orcid.org/0000-0003-1206-8355
2021.
Medullary thyroid cancer patient’s assessment of quality of life tools: results from the QaLM study.
European Thyroid Journal
10
(1)
, pp. 72-78.
10.1159/000509227
|
|
|
Willenbrock, Frances, Cox, Catrin M., Parkes, Eileen E., Wilhelm-Benartzi, Charlotte S. ORCID: https://orcid.org/0000-0003-4927-6158, Abraham, Aswin G., Owens, Robert, Sabbagh, Ahmad, Jones, Christopher M., Hughes, Daniel L. I., Maughan, Tim, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, O'Neill, Eric E. and Mukherjee, Somnath
2021.
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.
British Journal of Cancer
124
, pp. 581-586.
10.1038/s41416-020-01120-z
|
|
|
|
Jones, Robert H. ORCID: https://orcid.org/0000-0003-3576-9496, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Carucci, Margherita, Cox, Catrin, Butler, Rachel, Alchami, Fouad, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Bale, Catherine, Bezecny, Pavel, Joffe, Johnathan, Moon, Sarah, Twelves, Chris, Venkitaraman, Ramachandran, Waters, Simon, Foxley, Andrew and Howell, Sacha J.
2020.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial.
Lancet Oncology
21
(3)
, pp. 345-347.
10.1016/S1470-2045(19)30817-4
|
|
|